Two weeks ago, I (Psychedelic Alpha Editor Josh Hardman) visited Washington, D.C., to take the temperature on psychedelics among those who, whether through influence, expertise, or proximity to power, might shape the field’s future. From lawyers, lobbyists and advocacy groups to agency staffers, drug developers and well-connected individuals, I heard a wide array of views on where things stand…
